CORRECTION - Elevai Labs Inc.
November 14, 2024 14:35 ET
|
Elevai Labs Inc.
/CORRECTION/ Elevai Labs Inc. Reports Financial Results for the Third Fiscal Quarter of 2024 and Provides Business Update
Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update
November 14, 2024 09:08 ET
|
Elevai Labs Inc.
Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update
iMD Companies and Its Subsidiary Riize Health Announce Official Product Line Launch of Riize Hair
November 07, 2024 08:00 ET
|
iMD Companies, Inc.
RANCHO CORDOVA, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- iMD Companies, Inc. (OTC:ICBU) and its subsidiary Riize LLC (Riize Health) is pleased to announce the launch of its Riize Hair product line....
iMD Companies, Inc. Subsidiary Riize, LLC to Expand Product Line With Contracted Telemedicine Doctors
September 04, 2024 08:30 ET
|
iMD Companies, Inc.
New Products Include High Demand Hair Loss, Weight Loss, and Woman's Libido Products RANCHO CORDOVA, CA, Sept. 04, 2024 (GLOBE NEWSWIRE) -- iMD Companies, Inc. (OTC: ICBU) has completed the...
Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™
August 28, 2024 07:30 ET
|
Elevai Labs Inc.
Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondria
Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Product Line
June 28, 2024 09:00 ET
|
Elevai Labs Inc.
Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Product Line
Triple Hair Group reçoit l'approbation de l'EMA pour commencer les essais cliniques de phase III sur son médicament sur ordonnance Thérapie-07 en Europe
June 19, 2024 07:30 ET
|
Triple Hair Inc.
MONTRÉAL, 19 juin 2024 (GLOBE NEWSWIRE) -- Triple Hair Group Inc. (« Triple Hair » ou la « Société »), une société spécialisée dans le développement de traitements novateurs contre l'alopécie...
Triple Hair Group Receives EMA Approval to Start Phase III Clinical Trials on its Therapy-07 Prescription Drug in Europe
June 19, 2024 07:30 ET
|
Triple Hair Inc.
MONTRÉAL, June 19, 2024 (GLOBE NEWSWIRE) -- Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for androgenic alopecia,...
Triple Hair Group procède à la clôture d’un financement de 4 M$
June 03, 2024 07:30 ET
|
Triple Hair Inc.
MONTRÉAL, 03 juin 2024 (GLOBE NEWSWIRE) -- Triple Hair Group Inc. (« Triple Hair » ou la « Société »), une société spécialisée dans le développement de traitements novateurs contre l'alopécie...
Triple Hair Group Closes $4 Million Financing
June 03, 2024 07:30 ET
|
Triple Hair Inc.
MONTRÉAL, June 03, 2024 (GLOBE NEWSWIRE) -- Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for androgenic alopecia,...